Comparative Efficacy of Anti IL-4, IL-5 and IL-13 Drugs for Treatment of Eosinophilic Asthma: A Network Meta-analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comparative Efficacy of Anti IL-4, IL-5 and IL-13 Drugs for Treatment of Eosinophilic Asthma: A Network Meta-analysis

Published:2018-08-23 Issue:5 Volume:196 Page:517-530
ISSN:0341-2040
Container-title:Lung
language:en
Short-container-title:Lung

Author:

Iftikhar Imran H.,Schimmel Mathew,Bender William,Swenson Colin,Amrol David

Publisher

Springer Science and Business Media LLC

Subject

Pulmonary and Respiratory Medicine

Link

http://link.springer.com/article/10.1007/s00408-018-0151-5/fulltext.html

Reference49 articles.

1. McGrath KW, Icitovic N, Boushey HA, Lazarus SC, Sutherland ER, Chinchilli VM, Fahy JV, Asthma Clinical Research Network of the National Heart, Lung, and Blood Institute (2012) A large subgroup of mild-to-moderate asthma is persistently noneosinophilic. Am J Respir Crit Care Med 185:612–619

2. Carr TF, Zeki AA, Kraft M (2018) Eosinophilic and noneosinophilic asthma. Am J Respir Crit Care Med 197:22–37

3. Lambrecht BN, Hammad H (2015) The immunology of asthma. Nat Immunol 16:45–56

4. Chung KF, Wenzel SE, Brozek JL, Bush A, Castro M, Sterk PJ, Adcock IM, Bateman ED, Bel EH, Bleecker ER et al (2014) International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J 43:343–373

5. Kumar R, Singh J (2014) Biosimilar drugs: current status. Int J Appl Basic Med Res 4:63–66

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of biologic therapies on quality of life in severe asthma: Findings from the PRISM study;World Allergy Organization Journal;2024-09

2. Patient and clinician preferences for biologic treatments for severe uncontrolled asthma: a discrete choice experiment (DCE);Journal of Asthma;2024-08

3. Comparative Effectiveness of Mepolizumab, Benralizumab, and Dupilumab among Patients with Difficult-to-Control Asthma: A Multicenter Retrospective Propensity-matched Analysis;Annals of the American Thoracic Society;2024-06

4. Decoding treatment efficacy: uncovering response and failure dynamics to biologics in asthma;Expert Opinion on Biological Therapy;2024-01-05

5. Lung function trajectories in a cohort of patients with moderate‐to‐severe asthma on mepolizumab, omalizumab, or dupilumab;Allergy;2024-01-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3